ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Repligen Corp

Repligen Corp (RGEN)

166.21
-1.32
(-0.79%)
Closed February 02 4:00PM
166.21
0.11
(0.07%)
After Hours: 5:30PM

Repligen Corp Financial Summary

The current RGEN market cap is 9.31B. The company's latest EPS is USD 0.6353 and P/E is 261.45.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 172.46M148.64M151.35M154.07M161.47M
Operating Income 1.78M-7.76M2.03M1.49M-2.13M
Net Income 18.17M-31.47M2.09M3.32M2.94M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 270.25M366.26M670.53M830.27M662.93M
Operating Income 36.08M69.82M167.25M224.67M47.7M
Net Income 21.41M59.93M128.29M185.96M35.6M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 2.51B2.83B2.85B2.86B2.83B
Total Liabilities 525.57M866.34M878.67M875.56M813.96M
Total Equity 1.99B1.96B1.97B1.99B2.02B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.4B1.9B2.36B2.53B2.83B
Total Liabilities 340.35M373.74M608.29M620.9M866.34M
Total Equity 1.06B1.53B1.75B1.91B1.96B
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 84.85M113.92M44.71M86.9M136.22M
Investing 46.63M-123.28M-8.36M-15.76M-21.62M
Financing -19.17M248.96M-8.97M-14.75M-84.35M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 67.22M62.63M119.02M172.08M113.92M
Investing -205.31M-201.39M-221.17M-233.24M-123.28M
Financing 484.87M305.92M961k-13.34M248.96M
Market Cap 9.31B
Price to Earnings Ratio 261.45
Price to Sales Ratio 14.04
Price to Cash Ratio 12.39
Price to Book Ratio 4.74
Dividend Yield -

Share Statistics

Shares Outstanding 56.03M
Average Volume (1 week) 729.14k
Average Volume (1 Month) 625.35k
52 Week Change -13.45%
52 Week High 211.13
52 Week Low 113.50
Spread (Intraday) 60.29 (30.97%)

Company Info

Company Name Repligen Corp
Address 1209 orange street
wilmington, delaware 19801
Website https://www.repligen.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock